<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-PQ8ZUM9G</identifier><date>2019</date><creator>Mravljak, Janez</creator><creator>Plesničar, Tjaša</creator><relation>documents/doc/P/URN_NBN_SI_doc-PQ8ZUM9G_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PQ8ZUM9G_001.txt</relation><format format_type="issue">3</format><format format_type="volume">70</format><format format_type="type">article</format><format format_type="extent">str. 205-211</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">4765809</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PQ8ZUM9G</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">biološki označevalci</subject><subject language_type_id="slv">izoprostani</subject><subject language_type_id="slv">nevroprostani</subject><subject language_type_id="slv">Oksidativni stres</subject><subject language_type_id="slv">preeklampsija</subject><title>Isoprostanes and neuroprostanes as biomarkers of oxidative stress</title><title>Izoprostani in nevroprostani kot biološki označevalci oksidativnega stresa</title></Record>